Argatroban plus dual antiplatelet therapy versus dual antiplatelet alone for acute atherothrombotic cerebral infarction
The outcomes did not differ significantly between DAPT alone and argatroban combined with DAPT for acute atherothrombotic stroke.
Authors
- Kiyohide Fushimi (ORCID: https://orcid.org/0000-0002-1894-0290)
- Masashi Hamada (ORCID: https://orcid.org/0000-0002-2866-8067)
- Tatsushi Toda (ORCID: https://orcid.org/0000-0002-0717-1123)
- Taisuke Jo (ORCID: https://orcid.org/0000-0002-8503-022X)
- Shotaro Aso (ORCID: https://orcid.org/0000-0002-7804-2433)
- Toshiaki Isogai (ORCID: https://orcid.org/0000-0002-2172-6447)
- Saki Nakashima (ORCID: https://orcid.org/0000-0003-4227-4758)
- Satoshi Kodama (ORCID: https://orcid.org/0000-0002-0576-1859)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Yuichiro Shirota
- Hiroki Matsui (ORCID: https://orcid.org/0000-0003-3243-333X)
Institutions
- University of Tokyo Health Sciences (JP)
- Tokyo Metropolitan Tama Medical Center (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- International Journal of Stroke
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1177/17474930251344458
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ministry of Health, Labour and Welfare